COMBINATION-THERAPIES

COMBINATION-THERAPIES

Key Trends in the Pharmaceutical Pipeline for 2024 — Part I: Transformative R&D Growth Driven by Breakthroughs in Oncology, Neurological, and Metabolic Therapies

The pharmaceutical industry has been on a rollercoaster ride of innovation and growth, with the latest developments in 2024 showcasing a transformative surge in R&D. This growth is primarily driven by significant advancements in oncology, neurological, and metabolic therapies..

COMBINATION-THERAPIES

Prognosis and factors related to anti-VEGF therapy in patients with retinal vein occlusion and concomitant carotid artery disease

Retinal vein occlusion (RVO) is a condition where the veins of the retina are blocked, leading to vision loss..